Descripción de la empresa
ZeroStack Corp. operates primarily through its subsidiary, Phatebo GmbH, facilitating pharmaceutical distribution within the German market by handling commercial wholesale operations alongside a segment dedicated to digital assets. As a participant in the Financial Services sector specifically within the Asset Management industry, the company leverages its operational structure to distribute various pharmaceutical goods and medical products designed to treat diverse health indications. The enterprise maintains a market capitalization of $11.74M and generates annual revenue of $35.68M while employing a workforce of 21 individuals. These financial figures indicate that the company functions as a small-cap entity with a revenue scale significantly larger than its market valuation, suggesting a high growth potential or significant market inefficiency relative to its book value. The disparity between the $35.68M in revenue and the $11.74M market cap highlights a deep undervaluation based on traditional multiples, a common characteristic for asset-heavy or loss-making firms in niche distribution sectors where future earnings potential has not yet been reflected in current equity prices.
Salud financiera
ZeroStack Corp. reported total revenue of $35.68M for the trailing twelve months, yet this top-line activity was accompanied by a net income loss of $115,410,000 and an EBITDA of $-11,027,000. The substantial gap between the positive revenue of $35.68M and the severe net loss of $115.41M reveals a highly inefficient cost structure where operating expenses, likely including significant restructuring costs or asset impairments, far exceed gross profits. The company's free cash flow stands at $-5,176,000, which indicates a lack of financial flexibility and suggests that the business is burning cash rather than generating liquidity to fund operations or capital expenditures without external financing. Margin analysis shows a gross margin of 4.6%, an operating margin of -54.8%, and a profit margin of 0.0%, illustrating that while the cost of goods sold is low relative to sales, the overhead costs are so high that they erode nearly all operating income. On the balance sheet, the company holds $5.60M in cash against $53.93M in debt, resulting in a debt-to-equity ratio of 76.44, which characterizes the balance sheet as heavily leveraged and risky given the negative earnings. The current ratio is 1.01, indicating that the company's current assets are just barely sufficient to cover its current liabilities, leaving little room for error in short-term liquidity management. Furthermore, the return on equity is -307.5% and the return on assets is -9.3%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate returns.
Evaluación de valoración
ZeroStack Corp. does not have a trailing P/E ratio or a forward P/E ratio available, which implies that the market is pricing the stock based on fundamentals other than current or expected earnings per share, often seen in companies undergoing significant transformation or reporting losses. The price-to-book ratio is 0.07, a figure that indicates the market values the company at a fraction of its book value, suggesting a deep discount or a market perception that the assets listed on the balance sheet may not be recoverable at their book value. The price-to-sales ratio stands at 0.33, while the EV/EBITDA is -5.45, and these alternative valuation metrics suggest the stock is priced at a deep discount relative to its sales volume, though the negative EV/EBITDA reflects the company's inability to cover fixed costs with its earnings. The stock has traded between a 52-week high of $47.00 and a 52-week low of $4.78, meaning the current share price sits significantly below the recent peak, reflecting the severe financial distress and negative earnings that have depressed the valuation over the past year. The beta value is 2.01, which means the stock exhibits high volatility and is expected to move with twice the magnitude of the broader market, presenting elevated risk for investors seeking stability.
Growth & Income
ZeroStack Corp. achieved a revenue growth rate of 22.3% year-over-year, while earnings growth is N/A due to the reported net losses, indicating that top-line expansion is occurring despite the absence of profitability. Since the company is not a dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute income to shareholders, implying that any potential future earnings will be retained and reinvested into the business to fund operations or debt reduction. The overall growth and income profile is characterized by accelerating sales driven by digital asset and pharmaceutical distribution initiatives, yet this growth is currently insufficient to offset the heavy operational costs and debt obligations. The combination of strong revenue expansion with negative earnings and high leverage creates a high-risk, high-reward scenario where future valuation depends entirely on the company's ability to turn the operating losses into profits.